ABSTRACT
Background Prostate cancer is currently the second commonest male cancer in Uganda. Despite this, men are more likely to be tested for prostate cancer only after presenting with obstructive Lower urinary tract symptoms [1] since these are a common presenting complaint among elderly males [2]. However, there is still a lack of published local information on the clinical and biochemical patterns of prostate cancer among patients with lower urinary tract symptoms in Uganda which can negatively affects the equitable distribution of resources for cancer care.
Aims To determine the Patterns of PSA, DRE, histological findings, and prevalence of prostate cancer among patients presenting to Mbarara regional referral hospital with obstructive LUTS.
Materials and Methods A cross-sectional study of 140 patients with obstructive LUTS. Demographics, presenting symptoms were collected using a structured questionnaire and IPSS index, followed by total serum prostate specific antigen level estimation and Digital rectal examination. Patients who had a total serum Prostate Specific Antigen level above 4ng or an abnormal DRE underwent digitally guided transrectal prostate biopsy.
Results Majority had severe LUTS (n=103,73.57%) with a median tPSA of 14.4 ng/ml and met the criteria for the digitally guided transrectal trucut prostate biopsy(n=99,70.71%). DRE abnormalities were found in 57.14% n=80 of the participants. The commonest abnormalities were prostatic enlargement (n=76,54.29%), hard prostatic consistency (29.2% n=41), loss of the median groove (35.71% n= 50) and nodular prostate (n=60, 42.86%). The prevalence of prostate cancer was high at 52.21% (59/11395% C.I:30.1-46.3), and over 93.3% of the cancer postive patients exhibited abnormalities on DRE.
Prostate adenocarcinoma was the only histological type in all biopsies. The mean Gleason score was 8 (±1.148) and the majority had a Gleason score of 8 and above. (77.78%, n=35).
Conclusions The prevalence of prostate cancer among men presenting to Mbarara Regional referral hospital with obstructive LUTS was high and majority of these had poorly differentiated prostate adenocarcinoma.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Mbarara University OF SCIENCE AND uNIVERSITY Research and ethics committee
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Conflict of Interest No author conflict of interest exists.
Funding Statement This study was executed with funding from the First mile scholarship program
Data Availability
The data underlying the results presented in the study are available from wekib2014{at}gmail.com
